A Preliminary Analysis of Combined Liver Resection With New Chemotherapy for Synchronous and Metachronous Colorectal Liver Metastasis

Accepted 24 August 2009.

Objective

To compare the survival between patients with synchronous and metachronous colorectal liver metastases after hepatectomy with new generation of perioperative chemotherapy.

Methods

From October 2002 to January 2008, patients receiving hepatectomy for synchronous or metachronous colorectal liver metastasis were studied retrospectively.

Results

Fifty-five patients (synchronous group = 35, metachronous group = 20) underwent hepatectomy for colorectal liver metastases. Besides younger age with male predominance, patients in the synchronous group had more tumour multinodularity and bilobe liver involvement. They had received less hepatic curative hepatectomy (81.1% vs. 100%) with a higher rate of peri-operative chemotherapy (91.4% vs. 50%) and postoperative morbidity (25.7% vs. 0%). However both groups had no statistical significant difference in median overall survival (OS) and disease free survival (DFS). Inferior OS and DFS were observed in the synchronous group for patients who had no peri-operative chemotherapy or those showing poor response to chemotherapy. The most favourable OS is observed in both groups after performing globally curative hepatectomy.

Conclusion

Synchronous colorectal liver metastasis is not a poor prognostic factor for survival when compared with the metachronous metastasis. Globally curative hepatectomy in combination of new generation of chemotherapy is recommended for the management of resectable colorectal liver metastasis.

Key Words: chemotherapy , colorectal liver metastasis , metachronous , synchronous

No full text is available. To read the body of this article, please view the PDF online.

Article Outline

• Abstract

• References

• Copyright

References

1. 1 National Institute for Health and Clinical Excellence . Improving Outcomes in Colorectal Cancers: Manual Update . Available at: http://www.nice.org.uk/nicemedia/pdf/CSGCCfullguidance.pdf June 23, 2004; [Date accessed: 30 September 2008] .

2. 2 McArdle C . ABC of colorectal cancer: effectiveness of follow up . BMJ . 2000;321:1332–1335 .

3. 3 Scheele J . Hepatectomy for liver metastases . Br J Surg . 1993;80:274–276 . MEDLINE | CrossRef

4. 4 Adam R , Delvart V , Pascal G , et al. Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival . Ann Surg . 2004;240:644–657 . MEDLINE

5. 5 Fong Y , Fortner J , Sun RL , et al. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases . Ann Surg . 1999;230:309–318 . MEDLINE | CrossRef

6. 6 Choti MA , Sitzmann JV , Tiburi MF , et al. Trends in long-term survival following liver resection for hepatic colorectal metastases . Ann Surg . 2002;235:759–766 . MEDLINE | CrossRef

7. 7 Scheele J , Stang R , Altendorf-Hofmann A , et al. Resection of colorectal liver metastases . World J Surg . 1995;19:59–71 . MEDLINE | CrossRef

8. 8 Nordlinger B , Guiguet M , Vaillant J-C , et al. Surgical resection of colorectal carcinoma metastases to liver. A prognostic scoring system to improve case selection, based on 1568 patients . Cancer . 1996;77:1254–1262 .

9. 9 Hurwitz H , Fehrenbacher L , Novotny E , et al. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer . N Engl J Med . 2004;350:2335–2342 . CrossRef

10. 10 Nordlinger B , Halfdan S , Bengt G , et al. Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomized controlled trial . The Lancet . 2008;371:1007–1016 .

11. 11 Wang X , Hershman DL , Abrams JA , et al. Predictors of survival after hepatic resection among patients with colorectal liver metastasis . Br J Cancer . 2007;97:1606–1612 . CrossRef

12. 12 Miller AB , Hoogstraten B , Staquet M , et al. Reporting results of cancer treatment . Cancer . 1981;47:207–214 .

13. 13 Mitry E , Fields A , Bleiberg H , et al. Adjuvant chemotherapy after potentially curative resection of metastases from colorectal cancer. A meta-analysis of two randomized trials . J Clin Oncol . 2006;24:3524 . CrossRef

Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, The Chinese University of Hong Kong, Hong Kong SAR

Address correspondence and reprint requests to Professor Paul B.S. Lai, Department of Surgery, The Chinese University of Hong Kong, Prince of Wales Hospital, 30-32 Ngan Shing Street, Shatin, Hong Kong SAR

PII: S1015-9584(09)60394-8

doi:10.1016/S1015-9584(09)60394-8

1 of 11